These therapies offer a new horizon for patients who have struggled with traditional weight loss methods
Beyond their metabolic benefits, GLP-1 RAs exhibit neuroprotective and psychotropic effects, potentially benefiting mental health conditions like depression and anxiety
Why Joint Pain May Occur During GLP-1 Treatment Rapid weight loss altering joint biomechanics is the most likely indirect cause of joint pain during GLP-1 treatment, rather than a direct drug effect
Strategic partnerships between established players and regional distributors will likely accelerate global market penetration
Conclusion GLP-1 medications have catalyzed one of the most profound shifts in medical weight-loss care in decades
The weight loss mechanism differs as well: GLP-1 agonists work through delayed gastric emptying and central appetite suppression, while berberine's weight effects, when present, likely relate to improved insulin sensitivity and metabolic efficiency